Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer-Reference-Cited by-同舟云学术

Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer

Published:2017-03-08 Issue:4 Volume:26 Page:463-479
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Matsuda Naoko¹²,Lim Bora¹²,Wang Xiaoping¹²,Ueno Naoto T.¹²

Affiliation:

1. Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

2. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Funder

State of Texas Rare and Aggressive Breast Cancer Research Program

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1299707

Reference99 articles.

1. AKT/PKB and Other D3 Phosphoinositide-Regulated Kinases: Kinase Activation by Phosphoinositide-Dependent Phosphorylation

2. A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast Cancer

3. Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer

4. A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

5. TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyses of hypoxia-related risk factors and clinical relevance in breast cancer;Frontiers in Oncology;2024-03-04

2. In silico screening of chalcone derivatives as promising EGFR-TK inhibitors for the clinical treatment of cancer;3 Biotech;2023-12-19

3. HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel;Cancer Cell International;2023-09-16

4. HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells;npj Precision Oncology;2023-08-03

5. An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma;International Journal of Molecular Sciences;2023-07-05